Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLG) Operating Expenses (2016 - 2025)

Bone Biologics has reported Operating Expenses over the past 2 years, most recently at $1.3 million for Q4 2017.

  • Quarterly Operating Expenses fell 57.92% to $1.3 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2017, down 87.13% year-over-year, with the annual reading at $3.2 million for FY2025, 23.33% down from the prior year.
  • Operating Expenses was $1.3 million for Q4 2017 at Bone Biologics, up from $1.1 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $9.1 million in Q1 2016 and troughed at -$2.0 million in Q2 2017.